Search company, investor...

Predict your next investment

Corporation
mhtx.com

Investments

1

Portfolio Exits

2

Partners & Customers

6

About Manhattan Scientifics

Manhattan Scientifics is located in New Mexico, New York, and Montreal. The company's goal is to advance and commercialize disruptive technologies to create profit for its shareholders. It is focused on commercializing disruptive technology in the fields of nanotechnology and nanomedicine.

Headquarters Location

405 Lexington Avenue The Chrysler Building 26th Floor

New York, New York, 10174,

United States

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Manhattan Scientifics News

Imagion Expands Collaboration with Siemens Healthineers to United States

Jun 29, 2023

NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTC: MHTX ), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. For further details, please see Imagion Biosystems Press Release About Manhattan Scientifics, Inc. Manhattan Scientifics Inc. (www.mhtx.com) is focused on technology transfer and commercialization of transformative technologies. About Imagion Biosystems Imagion Biosystems (www.imagionbiosystems.

Manhattan Scientifics Investments

1 Investments

Manhattan Scientifics has made 1 investments. Their latest investment was in Novint Technologies as part of their Other Investors on .

CBI Logo

Manhattan Scientifics Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

Other Investors

Novint Technologies

Yes

Date

Round

Other Investors

Company

Novint Technologies

Amount

New?

Yes

Co-Investors

Sources

Manhattan Scientifics Portfolio Exits

2 Portfolio Exits

Manhattan Scientifics has 2 portfolio exits. Their latest portfolio exit was Imagion Biosystems on June 22, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/22/2017

IPO

$99M

Public

1

11/29/2016

Spinoff / Spinout

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/22/2017

11/29/2016

Exit

IPO

Spinoff / Spinout

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

1

10

Manhattan Scientifics Acquisitions

2 Acquisitions

Manhattan Scientifics acquired 2 companies. Their latest acquisition was Imagion Biosystems on June 15, 2011.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/15/2011

$99M

Acquired

6/13/2011

Subscribe to see more

$99M

Subscribe to see more

0

Date

6/15/2011

6/13/2011

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Sources

0

Manhattan Scientifics Partners & Customers

6 Partners and customers

Manhattan Scientifics has 6 strategic partners and customers. Manhattan Scientifics recently partnered with General Cable on July 7, 2016.

Date

Type

Business Partner

Country

News Snippet

Sources

7/25/2016

Partner

United States

Manhattan Scientifics Signs Development Agreement with General Cable

NEW YORK -- -- Manhattan Scientifics , Inc. announced today that it has signed a $ 500,000 Joint Development Agreement with General Cable .

2

7/25/2016

Partner

United States

Subscribe to see more

Subscribe to see more

10

11/12/2008

Partner

United States

Subscribe to see more

Subscribe to see more

10

7/8/2008

Partner

United States

Subscribe to see more

Subscribe to see more

10

3/18/2008

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

7/25/2016

7/25/2016

11/12/2008

7/8/2008

3/18/2008

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Manhattan Scientifics Signs Development Agreement with General Cable

NEW YORK -- -- Manhattan Scientifics , Inc. announced today that it has signed a $ 500,000 Joint Development Agreement with General Cable .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.